Memorial Sloan Kettering Cancer Commack (Limited Protocol Activities)

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Prostate cancer1 trial
• Sarcoma1 trial

Phase

• Phase 22 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• Memorial Sloan Kettering Cancer Center2 trials

Running trials

• Active, not recruiting

  Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma

  NCT04784247· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Active, not recruiting

  Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

  NCT04262154· Phase 2· Memorial Sloan Kettering Cancer Center· Source